Skip to content

Company Intelligence

BGI Genomics

华大基因

SZ: 300676Shenzhen, Guangdong, ChinaFounded 1999
BIOSECURE

BCC Designated (1260H)

BGI Group entities (BGI Genomics, MGI Tech, Complete Genomics) are on the DoD Section 1260H list and are near-certain BCC designees under BIOSECURE Category A. Federal contracts involving BGI entities will be prohibited after the transition period. Organizations using BGI for sequencing services should begin mapping alternative providers immediately.

0
Tracked Deals
3
Therapeutic Areas
3
Modalities

Overview

BGI Genomics (华大基因) is the world's largest genomics organization. BGI provides sequencing services, genetic testing, and bioinformatics analysis. The company and its subsidiaries (MGI Tech, Complete Genomics) are at the center of BIOSECURE Act concerns due to their position on the DoD Section 1260H list and the sensitive nature of genomic data.

Key Facts

  • On the DoD Section 1260H list — probable BCC designation under BIOSECURE Category A
  • World's largest genomics sequencing provider by volume
  • Subsidiaries include MGI Tech (sequencing instruments) and Complete Genomics (acquired 2013)
  • US government concerns center on genomic data security and military-civil fusion risks

Corporate Structure

BGI Group is the parent entity. Key subsidiaries: BGI Genomics (华大基因, SZ-listed), MGI Tech (华大智造, sequencing instruments), Complete Genomics (US-based, acquired 2013). Government connections have been a focus of congressional concern.